|
Title
|
|
|
|
Patient and caregiver outcomes after 6 ± 1.5-months of rivastigmine therapy for mild-to moderate Alzheimer's disease: the Belgian FExT study
| |
|
Author
|
|
|
|
| |
|
Institution/Organisation
|
|
|
|
FExT Study Group
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Current medical research and opinion. - London
| |
|
Publication
|
|
|
|
London
:
2007
| |
|
ISSN
|
|
|
|
0300-7995
| |
|
DOI
|
|
|
|
10.1185/030079907X226375
| |
|
Volume/pages
|
|
|
|
23
:10
(2007)
, p. 2485-2501
| |
|
ISI
|
|
|
|
000250555600020
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|